about
Monoclonal gammopathy of renal significance triggering atypical haemolytic uraemic syndrome.Recurrent atypical haemolytic uraemic syndrome post kidney transplant due to a CD46 mutation in the setting of SMARCAL1-mediated inherited kidney disease.Sirolimus Increases T-Cell Abundance in the Sun Exposed Skin of Kidney Transplant RecipientsIndoxyl sulphate and kidney disease: Causes, consequences and interventions.Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejection.Prophylactic and therapeutic adenoviral vector-based multivirus-specific T-cell immunotherapy for transplant patients.Tacrolimus Toxicity due to Biliary Obstruction in a Combined Kidney and Liver Transplant Recipient.Induction of transplantation tolerance converts potential effector T cells into graft-protective regulatory T cells.Association of Socio-Economic Position with Technique Failure and Mortality in Australian Non-Indigenous Peritoneal Dialysis Patients.Phosphate binders in patients with chronic kidney disease.BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.Temporal Changes in Deceased Kidney Donor Characteristics in Australia.Optimising assessment of kidney function when managing localised renal masses.Cryptococcal infections in solid organ transplant recipients over a 15-year period at a state transplant center.Factors associated with acutely elevated serum creatinine following radical tumour nephrectomy: the Correlates of Kidney Dysfunction-Tumour Nephrectomy Database study.The Correlates of Kidney Dysfunction – Tumour Nephrectomy Database (CKD-TUNED) Study: Protocol for a Prospective Observational StudyA comparison of graft and patient outcomes following kidney transplantation in extended hour and conventional haemodialysis patients.Outcome Measures Used to Report Kidney Function in Studies Investigating Surgical Management of Kidney Tumours: A Systematic Review.Autologous Adoptive T-cell Therapy for Recurrent or Drug-resistant Cytomegalovirus Complications in Solid Organ Transplant Recipients: A Single-arm Open-label Phase I Clinical TrialEnd-Stage Kidney Disease following Surgical Management of Kidney CancerPredictors of new-onset chronic kidney disease in patients managed surgically for T1a renal cell carcinoma: An Australian population-based analysisRenal failure complicating myeloma in pregnancyIndoxyl Sulfate Induces Apoptosis and Hypertrophy in Human Kidney Proximal Tubular CellsAssociation between preoperative hydration status and acute kidney injury in patients managed surgically for kidney tumoursThrombocytopenia secondary to passive transfer of anti-HPA 1a antibodies from male donor plasmaRecurrent severe hypophosphatemia following intravenous iron administrationIncident Chronic Kidney Disease After Radical Nephrectomy for Renal Cell CarcinomaChronic kidney cortical damage is associated with baseline kidney function and albuminuria in patients managed with radical nephrectomy for kidney tumours
P50
Q33439114-E355268B-12CC-4EC6-9588-0FAB189F1D0AQ33439122-F91CB19E-3D52-4534-B77A-3742259C27A3Q33873997-AF713823-3A0C-42B1-AF96-21768D4A6752Q35736317-8333197E-BC85-4FB1-AA83-15F84735C340Q35875359-CA8F0132-934E-411A-B3EF-06A951CC4F79Q37203522-52FF5201-2591-4DB5-8423-F5CA0014CCAAQ37598111-9B7181C6-4A22-4A8A-925D-76CD0427BDA7Q38491611-9D586DB5-8A93-49D1-96AE-3B4309E44129Q38968865-5F807BA9-29FF-4E82-A4AD-3D12850E2823Q39155279-B933F2E2-8D6F-4284-95AF-D1BFAED28838Q39180715-F11AAE61-8307-40DA-859C-C8EE0B1CDDC4Q39203012-7A30D912-823F-4B8A-B573-15D8B456BC3DQ40099212-786FA64B-E899-4377-A786-030C26BF699EQ40440693-2DFE1513-4B0A-4242-AB1D-5FC14AD5592DQ45763580-5E916037-94FC-4F0D-98A5-8F9613135A68Q47235364-B98EF519-7A32-4E87-8708-D75B42A8BB78Q48280931-5E6E649E-701B-4C10-8988-4DC7C96001DBQ53283673-84883256-7EB1-4C69-A05A-C50B94DDFB46Q57946450-2D663F16-D09A-4105-935B-DDE043477424Q61953189-2A84942D-DB94-4678-99AD-28C21D3D239FQ61953191-31F68CAA-BEE2-4184-96EB-E53B6FF8C9B5Q81309850-AC40AFC6-4F87-40AE-881F-9E5AFA214452Q88438435-CC8E620F-075F-4D3E-8531-79CDCC3AE817Q88993210-122CA3F1-4097-42B2-A3A6-C8AAEED646C3Q89006337-1F23ABA2-EDE9-4AD1-9C26-0213A2DA41E6Q90014699-A0E17CB9-78D1-4B11-BC6A-E8379BAE337EQ93038285-0347A417-CF2D-40FF-9501-D7B24FF3835CQ93379163-1F453C24-8576-4040-9041-5AD012E2C762
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Ross S Francis
@en
Ross S Francis
@nl
type
label
Ross S Francis
@en
Ross S Francis
@nl
prefLabel
Ross S Francis
@en
Ross S Francis
@nl
P31
P496
0000-0002-3995-7040